#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant oligodendroglioma Gastrointestinal neuroendocrine tumour Primary amyloidosis Neuroendocrine carcinoma metastatic Prodromal Alzheimer's disease Neutropenia Type IIa hyperlipidaemia Diffuse large B-cell lymphoma recurrent Leukaemia Familial dilated cardiomyopathy Congenital ectodermal dysplasia Kawasaki's disease Retinopathy proliferative Sickle cell anaemia Hidradenitis More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Basic Information Familial amyotrophic lateral sclerosis Short-bowel syndrome – Diagnostics Undifferentiated sarcoma – Diagnostics CADASIL Angiosarcoma non-metastatic – Life with Disease Hereditary optic atrophy – Diagnostics Lymphangioma Nodal marginal zone B-cell lymphoma – Treatment Sarcoidosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Moxifloxacin Hydrochloride Csm-Gw Gskvx000000009151 Methoxyflurane Iodixanol Cenobamate [18F]CPFPX Vorasidenib Febuxostat Hemihydrate Ibrutinib Buserelin Acetate Cefixime Trihydrate Lonapegsomatropin Loperamide Hydrochloride Erythromycin Lactobionate Anhydrous Caffeine Lenzumestrocel Tigecycline Rigosertib Sodium Lorlatinib More therapies…

    Learn about Your Condition

    Radicular pain Thyroid cancer metastatic Colon cancer stage III Obliterative bronchiolitis Burning mouth syndrome Renal cell carcinoma Autoimmune disorder Advanced systemic mastocytosis Osteochondrodysplasia Gout Adenocarcinoma gastric Eczema Morning sickness Endocarditis enterococcal Carcinoid tumour pulmonary More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endocarditis

  • Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Benzylpenicillin Sodium
    • Clindamycin Hydrochloride
    Belgium

  • Study on Shortened Antibiotic Treatment for Infectious Endocarditis Using Vancomycin, Meropenem, and Ceftriaxone for Patients with Left-Sided Heart Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis
    Investigated Drugs:
    • Ampicillin
    • Benzylpenicillin Sodium
    • Cloxacillin Sodium
    Sweden

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!